-
Consano Bio Receives FDA Investigational New Drug Clearance to Expand the C-1101 Chronic Sciatica Clinical Development Program into the United States
- July 20, 2026
- Posted by: Jessica Turner
- Category: Competitive research
No Comments
C-1101 is a potential first-in-class, disease-modifying, non-opioid therapy designed to address the underlying biology of chronic sciaticaBURLINGTON, Mass., July 20, 2026 /PRNewswire/ — Consano Bio, Inc., a clinical-stage biotechnology company advancing novel therapeutics designed to address serious, painful…
-
What Consumers Should Know About Liver Health Supplements Featuring Milk Thistle, Turmeric and Dandelion Root
- July 18, 2026
- Posted by: Jessica Turner
- Category: Competitive research
MANASSAS, Va., July 18, 2026 /PRNewswire/ — Liver wellness has become a growing focus in health conversations – and targeted nutritional support is a big part of why. PureHealth Research liver health supplements, built around a blend of Milk…
-
Innovative CBD-Coated Bedding Clinically Proven to Improve Sleep Quality: Song Beam Bedding and China Medical University’s Joint Study Published in International Journal Healthcare
- July 18, 2026
- Posted by: Jessica Turner
- Category: Competitive research
TAICHUNG, July 17, 2026 /PRNewswire/ — Song Beam Bedding Co., Ltd., a premier sleep solutions provider in Taiwan, announced that a clinical sleep research project it sponsored—led by Chinese medicine and pharmacology expert Juan-Cheng Yang, Ph.D., in collaboration with…